Stock analysts at Leede Financial issued their FY2027 earnings per share (EPS) estimates for Cipher Pharmaceuticals in a ...

Altogether, allocating $4,000 into these four healthcare stocks on the TSX offers a balanced approach to investing in a sector that combines stability with growth potential. Each company presents ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

‘Buy Canada’ is a popular endeavour in the current trade and political strife with the United States.

In a report released today, Justin Keywood from Stifel Nicolaus maintained a Buy rating on Knight Therapeutics (KHTRF – Research Report), with ...

Stifel Nicolaus analyst Justin Keywood maintained a Buy rating on Quipt Home Medical (QIPT – Research Report) today and set a price target of ...